Your browser doesn't support javascript.
loading
NUP214 Rearrangements in Leukemia Patients: A Case Series From a Single Institution.
Choi, Yu Jeong; Min, Young Kyu; Lee, Seung-Tae; Choi, Jong Rak; Shin, Saeam.
Afiliação
  • Choi YJ; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Min YK; Department of Laboratory Medicine, Severance Hospital, Seoul, Korea.
  • Lee ST; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Choi JR; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Shin S; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Ann Lab Med ; 44(4): 335-342, 2024 Jul 01.
Article em En | MEDLINE | ID: mdl-38145892
ABSTRACT

Background:

The three best-known NUP214 rearrangements found in leukemia (SET NUP214, NUP214ABL1, and DEKNUP214) are associated with treatment resistance and poor prognosis. Mouse experiments have shown that NUP214 rearrangements alone are insufficient for leukemogenesis; therefore, the identification of concurrent mutations is important for accurate assessment and tailored patient management. Here, we characterized the demographic characteristics and concurrent mutations in patients harboring NUP214 rearrangements.

Methods:

To identify patients with NUP214 rearrangements, RNA-sequencing results of diagnostic bone marrow aspirates were retrospectively studied. Concurrent targeted next-generation sequencing results, patient demographics, karyotypes, and flow cytometry information were also reviewed.

Results:

In total, 11 patients harboring NUP214 rearrangements were identified, among whom four had SETNUP214, three had DEKNUP214, and four had NUP214ABL1. All DEKNUP214-positive patients were diagnosed as having AML. In patients carrying SETNUP214 and NUP214ABL1, T-lymphoblastic leukemia was the most common diagnosis (50%, 4/8). Concurrent gene mutations were found in all cases. PFH6 mutations were the most common (45.5%, 5/11), followed by WT1 (27.3%, 3/11), NOTCH1 (27.3%, 3/11), FLT3-internal tandem duplication (27.3%, 3/11), NRAS (18.2%, 2/11), and EZH2 (18.2%, 2/11) mutations. Two patients represented the second and third reported cases of NUP214ABL1-positive AML.

Conclusions:

We examined the characteristics and concurrent test results, including gene mutations, of 11 leukemia patients with NUP214 rearrangement. We hope that the elucidation of the context in which they occurred will aid future research on tailored monitoring and treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Leucemia-Linfoma Linfoblástico de Células T Precursoras Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Leucemia-Linfoma Linfoblástico de Células T Precursoras Idioma: En Ano de publicação: 2024 Tipo de documento: Article